Literature DB >> 18841856

Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT.

Sabbir Hossain1, Ping Xia, Cynthia Chuang, Lynn Verhey, Alexander R Gottschalk, Guanwei Mu, Lijun Ma.   

Abstract

Hypofractionated stereotactic body radiotherapy (SBRT) has been tested for prostate cancer radiotherapy. This study aims to investigate the dosimetric effects of intrafraction prostate motion on the target and the normal structures for SBRT. For prostate cancer patients treated with an image-tracking CyberKnife system, the intrafraction prostate movements were recorded during 50-70 min treatment time. Based on the recorded intrafraction prostate movements, treatment plans were created for these cases using intensity modulated beams while scaling the average time patterns from the CyberKnife treatment to simulate hypofractionated intensity modulated radiotherapy (IMRT) delivery. The effect of delivery time on the intrafraction organ motion was investigated. For a nominal single fraction delivery of 9.5 Gy with IMRT, we found that the dosimetric effect of the intrafraction prostate movement is case dependent. For most cases, the dose volume histograms exhibited very small changes from the treatment plans that assumed no intrafractional prostate motion when the maximum intrafraction movements were within +/-5 mm. However, when sporadic prostate movements greater than 5 mm were present in any one direction, significant changes were found. For example, the V100, for the prostate could be reduced by more than 10% to less than 85% of the prostate volume coverage. If these large movements could be excluded by some active correction strategies, then the average V100% for the simulated plan could be restored to within approximately 2% of the ideal treatment plans. On average, the sporadic intrafraction motion has less dosimetric impact on the prolonged treatment delivery versus fast treatment delivery. For example, the average V100% for the clinical target volume was reduced from the original 95.1% to 92.1 +/- 3.7% for prolonged treatment, and to 91.3 +/- 5.4% when the treatment time was shortened by 50%. Due to the observed large sporadic prostate motions, we conclude that an on-line target motion monitoring and correction strategy is necessary to implement hypofractionated SBRT with intensity modulated beams for prostate cancer treatments.

Entities:  

Mesh:

Year:  2008        PMID: 18841856     DOI: 10.1118/1.2968333

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  14 in total

1.  Innovative image-guided CyberKnife stereotactic radiotherapy for bladder cancer.

Authors:  J Thariat; R Trimaud; G Angellier; M Caullery; J Amiel; P-Y Bondiau; J-P Gerard
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

Review 2.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

3.  Correlation and prediction uncertainties in the cyberknife synchrony respiratory tracking system.

Authors:  Eric W Pepin; Huanmei Wu; Yuenian Zhang; Bryce Lord
Journal:  Med Phys       Date:  2011-07       Impact factor: 4.071

4.  Optimizing fiducial visibility on periodically acquired megavoltage and kilovoltage image pairs during prostate volumetric modulated arc therapy.

Authors:  Pengpeng Zhang; Laura Happersett; Bosky Ravindranath; Michael Zelefsky; Gig Mageras; Margie Hunt
Journal:  Med Phys       Date:  2016-05       Impact factor: 4.071

5.  Clinical development of a failure detection-based online repositioning strategy for prostate IMRT--experiments, simulation, and dosimetry study.

Authors:  Wu Liu; Jianguo Qian; Steven L Hancock; Lei Xing; Gary Luxton
Journal:  Med Phys       Date:  2010-10       Impact factor: 4.071

6.  Analysis of prostate patient setup and tracking data: potential intervention strategies.

Authors:  Zhong Su; Lisha Zhang; Martin Murphy; Jeffrey Williamson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

7.  Dosimetric benefit of DMLC tracking for conventional and sub-volume boosted prostate intensity-modulated arc radiotherapy.

Authors:  Tobias Pommer; Marianne Falk; Per R Poulsen; Paul J Keall; Ricky T O'Brien; Peter Meidahl Petersen; Per Munck af Rosenschöld
Journal:  Phys Med Biol       Date:  2013-03-14       Impact factor: 3.609

8.  Intrafractional 3D localization using kilovoltage digital tomosynthesis for sliding-window intensity modulated radiation therapy.

Authors:  Pengpeng Zhang; Margie Hunt; Hai Pham; Grace Tang; Gig Mageras
Journal:  Phys Med Biol       Date:  2015-08-25       Impact factor: 3.609

9.  Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes.

Authors:  Debra E Freeman; Christopher R King
Journal:  Radiat Oncol       Date:  2011-01-10       Impact factor: 3.481

10.  A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

Authors:  Giampaolo Bolzicco; Maria Silvia Favretto; Ninfa Satariano; Enrico Scremin; Carmelo Tambone; Andrea Tasca
Journal:  BMC Urol       Date:  2013-10-17       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.